By Besting Herceptin, The Future Is Bright For MacroGenics
Seeking Alpha,
Summary Margetuximab has blockbuster potential boding well for MacroGenics as the data support initiation of a head to head…
Cancer immunology and immunotherapy
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 46 Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control
-
Altmetric BadgeChapter 47 Subversion and Coercion: The Art of Redirecting Tumor Immune Surveillance
-
Altmetric BadgeChapter 48 Dendritic cell subsets as vectors and targets for improved cancer therapy.
-
Altmetric BadgeChapter 49 Modulation of CTLA-4 and GITR for cancer immunotherapy.
-
Altmetric BadgeChapter 50 Cancer Immunology and Immunotherapy
-
Altmetric BadgeChapter 51 STAT3: a target to enhance antitumor immune response.
-
Altmetric BadgeChapter 69 Immunologically Active Biomaterials for Cancer Therapy
-
Altmetric BadgeChapter 70 Identification of Human Idiotype-Specific T Cells in Lymphoma and Myeloma
-
Altmetric BadgeChapter 81 Immunobiology of Cancer Therapies Targeting CD137 and B7-H1/PD-1 Cosignal Pathways
-
Altmetric BadgeChapter 89 Concepts and Ways to Amplify the Antitumor Immune Response
-
Altmetric BadgeChapter 94 Adoptive cellular therapy.
-
Altmetric BadgeChapter 95 Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin.
-
Altmetric BadgeChapter 114 LAG-3 in Cancer Immunotherapy
-
Altmetric BadgeChapter 120 Erratum to: Identification of Human Idiotype-Specific T Cells in Lymphoma and Myeloma
